Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last CNY37.45 CNY
Change Today -1.08 / -2.80%
Volume 8.7M
002550 On Other Exchanges
As of 3:00 AM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

changzhou qianhong biophar-a (002550) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/13/15 - CNY39.99
52 Week Low
04/29/14 - CNY15.10
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CHANGZHOU QIANHONG BIOPHAR-A (002550)

Related News

No related news articles were found.

changzhou qianhong biophar-a (002550) Related Businessweek News

No Related Businessweek News Found

changzhou qianhong biophar-a (002550) Details

Changzhou Qianhong Bio-pharma Co.,Ltd. provides various pharmaceutical products in China. The company offers circulatory system drugs, including pancreatic kallikrein enteric-coated tablets and injection grades that are used for microcirculation disorders, such as kidney disease, as well as used in the treatment of hypertension; and digestive system drugs for lack of appetite and indigestion. It also provides injection asparaginase for the treatment of acute lymphoblastic leukemia, acute myelogenous leukemia, acute monocytic leukemia, chronic lymphocytic leukemia, Hodgkin’s disease and non-Hodgkin’s lymphoma, and melanoma; and lipid-lowering drugs. In addition, the company offers cardiovascular and blood system drugs comprising heparin sodium injection for the prevention and treatment of thrombosis or thromboembolic disorders, as well as used in hemodialysis, cardiopulmonary bypass, catheterization, micro vascular surgery, and anticoagulated blood samples or instruments; and chondroitin sulfate to treat nervous headache, neuralgia, joint pains, atherosclerosis, and other diseases. Further, it provides Urokinase, which is used for the treatment of thromboembolic diseases, including acute extensive pulmonary embolism, chest pain, and myocardial infarction; and heparin. It also exports its products to Germany, Italy, the United States, Japan, Korea, India, Brazil, and other countries. The company was founded in 1971 and is based in Changzhou, China.

Founded in 1971

changzhou qianhong biophar-a (002550) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

changzhou qianhong biophar-a (002550) Key Developments

Changzhou Qianhong Biopharma Co.,Ltd. to Report Q3, 2014 Results on Oct 25, 2014

Changzhou Qianhong Biopharma Co.,Ltd. announced that they will report Q3, 2014 results on Oct 25, 2014

Changzhou Qianhong Biopharma Co.,Ltd. Announces Executive Elections

Changzhou Qianhong Biopharma Co.,Ltd. announced that it has elected Wang Yaofang, Zhao Gang, Jiang Wenqun, Wang Ke and Hai Tao as non-independent directors and Shao Rong, Zhang Jiwen, and Rong Xinghua as independent directors, at its 2nd extraordinary general meeting of 2014 held on September 10, 2014.

Changzhou Qianhong Biopharma Co.,Ltd., Special/Extraordinary Shareholders Meeting, Sep 10, 2014

Changzhou Qianhong Biopharma Co.,Ltd., Special/Extraordinary Shareholders Meeting, Sep 10, 2014., at 14:00 China Standard Time. Agenda: To elect Wang Yaofang, Zhao Gangm Jiang Wenqun, Wang Ke and Hai Tao as non-independent directors; to elect Shao Rong, Zhang Jiwen and Rong Xinghua as independent directors; to elect Jiang Jianping and Zhang Zhuqing as non-employee representative supervisors; and to decide remuneration for independent directors.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002550:CH CNY37.45 CNY -1.08

002550 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002550.
View Industry Companies

Industry Analysis


Industry Average

Valuation 002550 Industry Range
Price/Earnings 48.7x
Price/Sales 14.8x
Price/Book 5.9x
Price/Cash Flow 48.8x
TEV/Sales 14.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHANGZHOU QIANHONG BIOPHAR-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at